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 Aim
To investigate the influence of circulating bacterial 
DNA on
 • mortality
 • morbidity
 • levels of inflammatory markers
among a group of haemodialysis (HD) patients.
Background
 • Mortality rate among HD patients is > 20 %
 • Cardiovascular disease (CVD)  is the major     
  course of mortality
 •  There is a close relationship between inflamma- 
tion and development of CVD
 •  30-60% of HD patients have constantly elevated  
inflammation markers 
 •  Various factors in the uremic milieu can cause   
and sustain this inflammation
 •  Infection may be an important inflammatory 
factor as well
 •  Small studies have shown that approximately   
20% of a population of HD patients without any  
sign of clinical infection has circulating frag  
ments of bacterial DNA in the blood stream  
  - these patients do also have elevated hsCRP
Hypothesis
Chronic inflammation in HD patients may be caused 
by subclinical infection expressed by circulating bac-
terial DNA in the blood stream causing higher mor-
tality and morbidity 
Methods
Study population:
Haemodialysis patients treated in five different     
haemo dialysis facilities 
 • Aalborg
 • Skejby
 • Hjørring
 • Randers 
 • Horsens
Patients on chronic haemodialysis above 18 years of 
age and capable of understanding informed consent 
are eligible for inclusion.
Procedure:
 • Interview with baseline information
 • Physical examination
 • Blood sample drawn from peripheral vein and    
  from haemodialysis access
 • Nasal wipe
 • Dialysate samples
 • 100 HD patients will be re-examined after one    
  week repeating blood sampling
Blood samples:
 • Bacterial DNA - detected by using broad range    
  16S rDNA PCR.
 • Blood cultures
 • Inflammation markers: A number of markers from  
  different areas of the inflammatory response are  
  analyzed
 •  Baseline parameters: Electrolytes, lipids, hemo-
globin, creatinine, urea
Primary end point:
 • all cause mortality 
Secondary end points: 
 • bacteraemia 
 • cardiovascular death
 • cardiovascular events
 • hospital admissions 
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AMONG HAEMODIALYSIS PATIENTS
Design
 • Cohort study
 • 2 year follow up
Study population:
 419 patients
 80 patients excluded:
     60 did not meet inclusion criteria
     20 refused to participate
339 accepted inclusion
2 patients died waiting for inclusion program
337 patients included December 6th 2010 
until March 29th 2011
